Show simple item record

dc.contributor.authorBENNETT, KATHLEENen
dc.date.accessioned2016-07-12T13:16:21Z
dc.date.available2016-07-12T13:16:21Z
dc.date.issued2013en
dc.date.submitted2013en
dc.identifier.citationGodman, B. Persson, M. Miranda, J. Barbui, C. Bennie, M. Bennett, K. Bucsics, A. Simoens, S. Zara, C. Gustafsson, L. L., Can authorities take full advantage of the availability of generic atypical antipsychotic drugs? implications for the future, Clinical Therapeutics, 35, 8, 2013, 99 - 100en
dc.identifier.otherYen
dc.identifier.urihttp://hdl.handle.net/2262/76694
dc.descriptionPUBLISHEDen
dc.format.extent99en
dc.format.extent100en
dc.relation.ispartofseriesClinical Therapeuticsen
dc.relation.ispartofseries35en
dc.relation.ispartofseries8en
dc.rightsYen
dc.titleCan authorities take full advantage of the availability of generic atypical antipsychotic drugs? implications for the futureen
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/bennettken
dc.identifier.rssinternalid92309en
dc.rights.ecaccessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record